If you read my recent article about Nrf2, you’ll already have met one of the body’s fascinating cellular defence systems.
Nrf2 is a transcription factor — essentially a protein involved in switching particular genes on. When our cells encounter certain forms of stress, Nrf2 can help coordinate the expression of genes involved in antioxidant defence, cellular protection and our response to oxidative stress.
But Nrf2 doesn’t work in isolation.
It’s part of a complex network of signalling pathways, influenced by what’s happening both inside and outside our cells.
And one area attracting increasing research interest is the interaction between functional mushrooms and these cellular pathways.
So, what do mushrooms have to do with Nrf2?
Quite a lot, potentially — but as always, the science is more interesting than simply saying that mushrooms “activate Nrf2”.
Functional mushrooms are chemically complex
We sometimes talk about a functional mushroom as though it contains one active ingredient responsible for its effects.
It doesn’t.
Mushrooms contain a remarkably diverse collection of naturally occurring compounds, and different mushroom species have different biochemical profiles.
A recent scientific review examining mushroom bioactives identified four particularly important groups:
- polysaccharides, including β-glucans
- triterpenoids
- phenolic compounds
- bioactive peptides
These compounds appear to interact with different parts of our immune, inflammatory and cellular signalling networks.
And that’s important.
Rather than thinking of functional mushrooms as substances that perform one particular job, researchers are increasingly investigating them as multi-compound foods capable of interacting with multiple biological pathways.
One of those pathways is Nrf2.
How might functional mushrooms interact with Nrf2?
When Nrf2 is activated appropriately, it can move into the nucleus of the cell and stimulate the expression of genes involved in our own antioxidant and cytoprotective defences.
A scientific review of bioactive compounds isolated from edible fungi examined several ways mushroom compounds may interact with the Keap1/Nrf2/ARE pathway.
The researchers looked at polysaccharides, peptides and polyphenols and found evidence of several potential routes through which these compounds can influence Nrf2 signalling.
A newer review published in Frontiers in Nutrition also identifies the Nrf2/HO-1 pathway as one of the key signalling pathways modulated by mushroom bioactives, with potential effects on endogenous antioxidant defence and oxidative stress.
This doesn’t mean taking a functional mushroom supplement simply flips an Nrf2 switch.
As we saw in my previous article, Nrf2 itself behaves much more like a rheostat or dimmer switch than a simple ON/OFF mechanism.
And mushroom compounds appear to be similarly nuanced.
It’s not only about beta-glucans
Beta-glucans are probably the best-known compounds associated with functional mushrooms.
They’re polysaccharides found in fungal cell walls and have been studied particularly for their interaction with the immune system.
The recent review describes fungal β-glucans interacting with pattern-recognition receptors including Dectin-1 and complement receptor 3 (CR3).
But concentrating entirely on beta-glucans means we miss much of the story.
Triterpenoids, phenolic compounds and peptides may interact with cellular pathways in different ways.
The research reviewed includes not only Nrf2, but pathways such as NF-κB, MAPK and the NLRP3 inflammasome — all of which have roles in inflammatory and cellular responses.
That gives us a much more interesting picture.
Instead of one compound acting on one biological target, we have numerous compounds interacting with a network of cellular signals.
Nrf2 and inflammation are connected
This is also where our recent conversations about immune balance rather than immune boosting become relevant again.
Oxidative stress and inflammation aren’t completely separate processes.
Cellular signalling pathways communicate with one another, and Nrf2 has important relationships with inflammatory signalling.
The newer mushroom review discusses cross-talk between Nrf2 and NF-κB, one of the major regulators of inflammatory gene expression.
The researchers ultimately describe mushroom bioactives as potentially acting through several mechanisms rather than indiscriminately suppressing inflammation. Their review brings together evidence involving Nrf2-mediated antioxidant responses alongside NF-κB, MAPK and NLRP3 signalling.
Again, the important word here is regulation.
We need inflammatory responses. We need reactive oxygen species. We need cellular stress signals.
Health isn’t about eliminating all of them.
It’s about retaining the ability to respond appropriately and return towards balance.
And then there’s ergothioneine
Another particularly interesting compound associated with mushrooms is ergothioneine.
Ergothioneine is a naturally occurring amino-acid derivative with antioxidant properties. Mushrooms are an important dietary source, and researchers are increasingly interested in its potential role in cellular protection.
This gives us another connection with the broader Nrf2 story: rather than viewing antioxidants simply as substances that “mop up” free radicals, we’re beginning to understand a much more complicated system involving antioxidant compounds, cellular signalling and the body’s own endogenous defence mechanisms.
And ergothioneine itself is another area where research is continuing to evolve.
It’s fascinating.
But fascinating isn’t the same thing as clinically proven.
Different mushrooms contain different compounds
This is another reason I don’t particularly like talking about “mushrooms” as though they’re all interchangeable.
They’re not.
Reishi (Ganoderma), Cordyceps, Shiitake (Lentinula), Maitake (Grifola), Chaga (Inonotus) and other functional mushrooms contain different combinations and concentrations of bioactive compounds.
The recent review found distinct profiles among different mushroom species and argues that these differences are relevant to their biological activity.
Cordyceps, for example, contains compounds including cordycepin alongside polysaccharides and sterols, while Reishi contains characteristic triterpenoids as well as β-glucans.
So asking:
“Are functional mushrooms good for Nrf2?”
may ultimately be far too broad a question.
Which mushroom? Which compounds? Which extraction method? At what concentration? And in which person?
Those details matter.
Quality and extraction matter too
This is perhaps one of the most useful findings for anyone actually buying functional mushroom products.
Two products with “Reishi” written on the label aren’t necessarily chemically equivalent.
The research highlights substantial variability in the amounts of active compounds found in commercial mushroom preparations. Differences in cultivation, harvesting and extraction can all affect the final biochemical profile.
Extraction method can make a significant difference too.
The review describes substantial variation in triterpenoid content depending upon extraction technique, for example.
So when we’re discussing research into functional mushrooms, quality, species, preparation and standardisation really do matter.
A research finding about a particular extract cannot automatically be applied to every mushroom powder or supplement containing the same species.
What does the human evidence show?
This is where we need to put the brakes on slightly.
There’s a considerable amount of laboratory and preclinical research exploring mushroom bioactives, oxidative stress, inflammation and signalling pathways such as Nrf2.
But the newer review makes an important point:
Human clinical evidence remains much more limited.
It identifies relatively few randomised controlled trials of mushroom interventions in chronic inflammatory disease compared with the amount of preclinical research available.
There are other challenges too.
Bioavailability can be poor for some mushroom compounds, particularly high-molecular-weight polysaccharides, and researchers are still working on questions around extraction, dosing, absorption and standardisation.
So although the molecular mechanisms are intriguing, we shouldn’t leap from:
“This mushroom compound influenced Nrf2 in a laboratory model”
to:
“Taking this mushroom supplement will activate Nrf2 and prevent disease.”
Those are two very different claims.
So where does this leave functional mushrooms?
For me, it makes them more interesting, not less.
The emerging picture isn’t one of a miracle food switching on a single beneficial pathway.
It’s of biologically complex organisms containing multiple compounds that may interact with our own equally complex regulatory systems.
And that’s very different.
It also fits beautifully with something I return to again and again in nutritional therapy:
Health isn’t simply about boosting things.
A healthy immune system isn’t permanently activated.
A healthy inflammatory response isn’t permanently suppressed.
And, as we saw with Nrf2, a healthy cellular defence system isn’t necessarily one that’s permanently switched to maximum.
What we want is the capacity to sense, respond, regulate, adapt and recover.
Functional mushrooms may prove to have an interesting place within that picture.
The research is developing rapidly, and there are still significant questions to answer — particularly around standardisation, bioavailability, appropriate dosing and what happens in humans over the longer term.
But we’re beginning to understand far more about the sophisticated chemistry contained within these extraordinary fungi.
And we’re discovering that their relationship with our biology may be much more nuanced than the old phrase “immune boosting” ever suggested.
New to Nrf2?
Read my previous article: Meet Nrf2: The Cellular Defence System You’ve Probably Never Heard Of
